Sign in

CIK 0000728387

  • Non-accelerated filer
  • Smaller reporting company

Perspective Therapeutics, Inc.

Sign in to watch
Ticker
CATX
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
411458152
Phone
+1 206-676-0900
Business address
2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
Former names
IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
Open-market buys, last 90 days
$163,386
in 7 filings
Open-market sales, last 90 days
$1,622,534
in 5 filings

Net −$1,459,148. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-11-17 Williamson Robert F III Director Purchase +25,000 $0.84 $21K 53,473
2026-11-16 Morich Frank Director Purchase +15,000 $0.94 $14K 30,000
2026-11-12 Morich Frank Director Purchase +15,000 $1.00 $15K 15,000
2026-11-12 Williamson Robert F III Director Purchase +18,609 $0.84 $16K 28,473
2026-11-12 Williamson Robert F III Director Purchase +6,289 $0.84 $5K 115,271
2026-11-12 Woods Lori A Director Purchase +23,750 $0.84 $20K 28,557
2026-11-12 Puhlmann Markus Chief Medical Officer Purchase +35,000 $0.84 $30K 178,542
2026-11-11 Puhlmann Markus Chief Medical Officer Purchase +6,000 $0.83 $5K 143,542
2026-11-11 Spoor Johan M. Chief Executive Officer Purchase +47,000 $0.81 $38K 106,383
2026-09-04 Lantheus Alpha Therapy, LLC 10% owner Sale −167,149 $3.15 $526K 11,273,364
2026-09-03 Lantheus Alpha Therapy, LLC 10% owner Sale −80,783 $3.11 $251K 11,440,513
2026-09-02 Lantheus Alpha Therapy, LLC 10% owner Sale −42,129 $3.11 $131K 11,521,296
2026-09-01 Lantheus Alpha Therapy, LLC 10% owner Sale −35,769 $3.12 $112K 11,563,425
2026-09-01 Lantheus Holdings, Inc. 10% owner Sale −35,769 $3.12 $112K 11,563,425
2026-08-31 Lantheus Alpha Therapy, LLC 10% owner Sale −78,145 $3.14 $246K 11,599,194
2026-08-31 Lantheus Holdings, Inc. 10% owner Sale −78,145 $3.14 $246K 11,599,194
2026-03-02 Puhlmann Markus Chief Medical Officer Grant or award · Stock option (right to buy) +150,000 150,000
2026-03-02 Martinez Maria E Director Grant or award · Stock option (right to buy) +50,000 50,000
2026-03-02 Morich Frank Director Grant or award · Stock option (right to buy) +50,000 50,000
2026-03-02 Spoor Johan M. Chief Executive Officer Grant or award · Stock option (right to buy) +735,000 735,000

Page 1 of 26 · 510 trades